VIA
ABBV icon

Vantage Investment Advisors’s AbbVie ABBV Stock Holding History

Vantage Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$78K Buy
1,017
+198
+24% +$18.8K 0.02% 225
2018
Q2 		$76K Sell
819
-99
-11% -$9.67K 0.02% 227
2018
Q1 		$87K Buy
918
+3
+0.3% +$330 0.02% 215
2017
Q4 		$89K Hold
915
– – 0.02% 220
2017
Q3 		$81K Buy
915
+1
+0.1% +$76 0.02% 216
2017
Q2 		$66K Sell
914
-472
-34% -$31.7K 0.02% 225
2017
Q1 		$90K Buy
1,386
+161
+13% +$10.1K 0.03% 188
2016
Q4 		$77K Buy
1,225
+101
+9% +$6.17K 0.03% 195
2016
Q3 		$71K Sell
1,124
-331
-23% -$21.4K 0.03% 205
2016
Q2 		$88K Buy
1,455
+402
+38% +$24.5K 0.04% 188
2016
Q1 		$60K Buy
1,053
+1
+0.1% +$56 0.03% 226
2015
Q4 		$62K Buy
1,052
+302
+40% +$17.4K 0.03% 217
2015
Q3 		$41K Hold
750
– – 0.02% 243
2015
Q2 		$50K Sell
750
-672
-47% -$43.9K 0.03% 241
2015
Q1 		$83K Buy
1,422
+972
+216% +$58.7K 0.02% 264
2014
Q4 		$29K Hold
450
– – 0.02% 315
2014
Q3 		$26K Hold
450
– – 0.02% 311
2014
Q2 		$25K Hold
450
– – 0.02% 334
2014
Q1 		$23K Buy
450
+300
+200% +$15.2K 0.02% 316
2013
Q4 		$8K Buy
+150
New +$7.37K 0.01% 417

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vantage Investment Advisors's ABBV Position: Q3 2018 in Review

Vantage Investment Advisors increased its AbbVie (ABBV) stake by 24% in Q3 2018, buying an estimated $18.8K and bringing the position to 1,017 shares worth $78K. The position accounts for 0.02% of the portfolio, ranked #225.

Vantage Investment Advisors first reported a position in ABBV in Q4 2013 and has held it in 20 quarters since. The position peaked at $90K in Q1 2017. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

  • Vantage Investment Advisors held 1,017 shares of AbbVie worth $78K as of Q3 2018.
  • Vantage Investment Advisors bought 198 AbbVie shares in Q3 2018, an estimated $18.8K.
  • AbbVie made up 0.02% of Vantage Investment Advisors's portfolio in Q3 2018, its #225 holding.
  • Vantage Investment Advisors first reported a position in AbbVie in Q4 2013 and has held it in 20 quarters since.
  • Vantage Investment Advisors's AbbVie position peaked at $90K in Q1 2017.
  • 1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.